Lunaphore was born out of 9 years of R&D at the Swiss Federal Institute of Technology and develops laboratory automation solutions with potential for cancer research and tissue diagnostics* based on a unique microfluidic technology, called Fast Fluidic Exchange (FFeX).
Lunaphore’s overall goal is to decrease assay time while maintaining the quality of its results.